1. Home
  2. BTU vs TARS Comparison

BTU vs TARS Comparison

Compare BTU & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peabody Energy Corporation

BTU

Peabody Energy Corporation

HOLD

Current Price

$22.88

Market Cap

2.8B

Sector

Energy

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$58.46

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTU
TARS
Founded
2016
2016
Country
United States
United States
Employees
6600
N/A
Industry
Coal Mining
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.7B
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
BTU
TARS
Price
$22.88
$58.46
Analyst Decision
Strong Buy
Buy
Analyst Count
9
6
Target Price
$32.83
$89.00
AVG Volume (30 Days)
2.3M
1.4M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.09%
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
$3,861,500,000.00
$451,360,000.00
Revenue This Year
$17.96
$56.43
Revenue Next Year
$5.47
$30.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
146.71
52 Week Low
$14.25
$38.51
52 Week High
$41.14
$85.25

Technical Indicators

Market Signals
Indicator
BTU
TARS
Relative Strength Index (RSI) 42.21 45.13
Support Level $21.96 $56.05
Resistance Level $24.53 $67.14
Average True Range (ATR) 0.95 3.54
MACD 0.15 -0.35
Stochastic Oscillator 31.91 23.72

Price Performance

Historical Comparison
BTU
TARS

About BTU Peabody Energy Corporation

Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan, and other regions.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: